Alternative Data for Teva Pharmaceutical
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 386 | Sign up | Sign up | Sign up |
| Sentiment | 86 | Sign up | Sign up | Sign up |
| Webpage traffic | 122,000 | Sign up | Sign up | Sign up |
| Employee Rating | 72 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 116 | Sign up | Sign up | Sign up |
| Facebook Followers | 61,232 | Sign up | Sign up | Sign up |
| Reddit Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 22 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 26,967 | Sign up | Sign up | Sign up |
| X Followers | 10,797 | Sign up | Sign up | Sign up |
| X Mentions | 15 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 8,710 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 53 | Sign up | Sign up | Sign up |
| Linkedin Employees | 29,988 | Sign up | Sign up | Sign up |
About Teva Pharmaceutical
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals.
| Price | $32.53 |
| Target Price | Sign up |
| Volume | 14,130,000 |
| Market Cap | $36.5B |
| Year Range | $15.38 - $32.79 |
| Dividend Yield | 0% |
| PE Ratio | 52.15 |
| Analyst Rating | 86% buy |
| Industry | Drug Manufacturers |
In the news
 |
Teva Pharmaceutical Industries Limited (TEVA) Presents at 44th Annual J.P. Morgan Healthcare Conference - SlideshowJanuary 13 - SeekingAlpha |
|
Teva Pharmaceutical Industries Limited (TEVA) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptJanuary 12 - SeekingAlpha |
 |
Truist Lifts PT on Teva Pharmaceutical Industries (TEVA) to $36 From $32January 10 - Yahoo Entertainment |
Bioidentical Hormones Market Size to Reach USD 5.51 Billion by 2033, Driven by Personalized Hormone Therapy Adoption and Rising Menopausal Care Demand – SNS InsiderJanuary 27 - GlobeNewswire |
|
Prescription Weight Loss Medications Market Projected to Reach US$ 40.13 Billion by 2035, Supported by Clinical Adoption and Pipeline Expansion Says Astute AnalyticaJanuary 26 - GlobeNewswire |
|
FRMI SHAREHOLDERS: Fermi Inc. Accused of Misrepresentations about its Customer Agreement in Securities Fraud Class Action – Investors Notified to Contact BFA LawJanuary 26 - GlobeNewswire |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 4.48B | 2.18B | 2.3B | 433M | 1.11B | 0.780 |
| Q2 '25 | 4.18B | 2.07B | 2.1B | 282M | 657M | 0.660 |
| Q1 '25 | 3.89B | 2.01B | 1.88B | 214M | 763M | 0.520 |
| Q4 '24 | 4.23B | 2.11B | 2.12B | -217M | 1.16B | 0.710 |
| Q3 '24 | 4.33B | 2.18B | 2.15B | -437M | 207M | -0.390 |
Insider Transactions View All
| Weiss Amir filed to sell 5,650 shares at $30.2. December 18 '25 |
| MIGNONE ROBERTO filed to sell 367,600 shares at $30.2. December 18 '25 |
| Daniell Richard filed to sell 48,384 shares at $28.7. December 11 '25 |
| Sabag Mark filed to sell 52,828 shares at $28.7. December 11 '25 |
| Sabag Mark filed to sell 150,996 shares at $28.7. December 11 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$224.44 1.3% | 44 |
 |
Eli Lilly and CompanyLLY |
$1039.51 2.2% | 62 |
 |
PfizerPFE |
$26.5 2.4% | 51 |
 |
AstrazenecaAZN |
$95.6 1.5% | 49 |
 |
AbbVieABBV |
$223.93 1.4% | 53 |
Read more about Teva Pharmaceutical (TEVA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Teva Pharmaceutical
The Market Cap of Teva Pharmaceutical is $36.5B.
As of today, Teva Pharmaceutical's PE (Price to Earnings) ratio is 52.15.
Currently, the price of one share of Teva Pharmaceutical stock is $32.53.
The TEVA stock price chart above provides a comprehensive visual representation of Teva Pharmaceutical's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Teva Pharmaceutical shares. Our platform offers an up-to-date TEVA stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Teva Pharmaceutical (TEVA) does not offer dividends to its shareholders. Investors interested in Teva Pharmaceutical should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Teva Pharmaceutical are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
